According to a recent study by the Journal of Trace Elements in Medicine and Biology, there may be cause for concern over the aluminum hydroxide commonly used as an adjuvant in vaccines.
Adjuvants are used to “increase” the efficacy of a vaccine by promoting antibody titers. How they do this, though, is by manipulating the immune system through hyper-sensitization. It’s the immune system’s equivalent to poking a bear.
The concern with aluminum hydroxide is that it is causing aluminum overload at injection sites, and contributing to the onset of diseases and conditions such as chronic fatigue syndrome, macrophagic myofasciitis and a variety of skin lesions. The report discusses the case of a 45-year old woman with a vaccine-induced subcutaneous pseudolymphoma, a type of skin lesion. A biopsy performed on the lesion found extremely high concentration of aluminum hydroxide in her tissues.
The researchers cautioned, “…The possible release of Al may induce other pathologies ascribed to the well-known toxicity of this metal.”
It’s also documented in a report by Current Medical Chemistry that aluminum hydroxide and it’s effects on humans in vaccines isn’t that well documented, but experimental research shows that aluminum can indeed induce serious medical consequences.